verapamil has been researched along with dolastatin 10 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assaraf, YG; Borgnia, MJ; Eytan, GD | 1 |
| Croop, J; Kufe, DW; Slapak, CA; Toppmeyer, DL | 1 |
| Aherne, GW; Bryant, A; Hardcastle, A; Kelland, LR; Pettit, GR; Rogers, P; Srirangam, JK; Valenti, M | 1 |
3 other study(ies) available for verapamil and dolastatin 10
| Article | Year |
|---|---|
Competition of hydrophobic peptides, cytotoxic drugs, and chemosensitizers on a common P-glycoprotein pharmacophore as revealed by its ATPase activity.
Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; CHO Cells; Clone Cells; Computer Simulation; Cricetinae; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Emetine; Gramicidin; Ionophores; Kinetics; Mathematics; Models, Theoretical; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Valinomycin | 1996 |
Role of P-glycoprotein in dolastatin 10 resistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Line; Cricetinae; Depsipeptides; Drug Resistance; Humans; Membrane Glycoproteins; Mice; Oligopeptides; Phenotype; Transfection; Verapamil | 1994 |
Antitumour evaluation of dolastatins 10 and 15 and their measurement in plasma by radioimmunoassay.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Division; Colonic Neoplasms; Cross Reactions; Depsipeptides; Drug Resistance, Multiple; Female; Half-Life; Humans; Injections, Intravenous; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oligopeptides; Ovarian Neoplasms; Rabbits; Radioimmunoassay; Random Allocation; Transplantation, Heterologous; Tumor Cells, Cultured; Verapamil | 1996 |